ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Affluence Corporation Announces Entry into $7.6 Billion Biomedical Waste Market Through Acquisition of Saamarthya

OAK BROOK, IL / ACCESSWIRE / October 5, 2021 / Affluence Corporation (OTC PINK:AFFU), a diversified technology company focusing on innovative Smart Cities, IoT and 5G enhancing technologies announced today that the company has signed a "Letter of Intent" to acquire Saamarthya Management Consultancy P Ltd, India enabling entry into the exploding $7.6 Billion Biomedical space with an innovative IoT solution. Saamarthya is a premier organization operating as an accelerator supporting multiple start-ups and owns the intellectual property rights or exclusive distribution rights to multiple businesses that have developed leading edge technologies in the IoT space. This acquisition enhances Affluence's commitment to building a world class IoT and 5G company.

"The acquisition of Saamarthya will enable us to continue to build on our strategy of developing a strong portfolio of products and value-added services in the IoT space that are aligned with business opportunities arising due to increasing adoption of IoT solutions in global markets," said James E. Honan, Jr., Affluence's Global CEO. "The initial technology that we will bring to market is an IoT based Biomedical Waste Management and Bar Code solution that employs multiple IoT Technologies including an ERP solution which is deployed to control and monitor of end-to-end management and collection of transportation, treatment, and disposal of biomedical waste generated at Healthcare Establishments (HCE) such as hospitals, polyclinics and labs. This solution is already implemented in 10 of the 275 operators in India covering more than 40,000 HCE's and efficiently manages the entire cycle of collection, transportation, treatment, and disposal of biomedical waste. Our pro-forma revenue estimates for next year based on our current installed base is approximately $3 million. Further discussions are underway for implementation with the remaining operators across India and we are forecasting penetration into 100 of the 275 operators in India by the end of 2022 as well as in other geographies," said Honan.

"The global biomedical waste management market is growing at a CAGR of 5.8% per year and will be $12.8 billion by 2030," said Avinash Bector, President & CEO, Affluence Corp for Asia & Africa markets. "Government agencies throughout the globe are issuing new mandates for biomedical waste management. This IoT solution is a ground breaking technological approach which is unlike anything currently on the market and is already in use and gaining more acceptance everyday. In addition to the biomedical waste management solution, we are very excited about the other IoT solutions that Saamarthya brings which address other large market segments and we plan to roll out more of them by the end of 2021," said Bector.

About Affluence Corporation

Affluence Corporation (AFFU.PK) is a diversified technology company focused on edge computing and innovative cloud solutions that capitalize on IoT, AI and 5G technologies. We are investing in mid-market businesses to create a cohesive unit which brings together technology for the next generation of internet.

About OneMind Technologies SL

OneMind Technologies SL is a wholly owned subsidiary of Affluence Corporation. The OneMind Intelligent IoT solution builder is used to create applications for smart construction and smart city operations. Functioning as systems of systems, OneMind connects data sources to one single point of insight to provide real-time information on operational processes. It is a key component in the enterprise solutions currently being offered by several Fortune 50 companies that resell, distribute, and integrate smart city enterprise solutions. https://www.onemindtechnologies.com

About Saamarthya Management Consultancy P. Ltd.

Saamarthya is operating in India as an "ACCELERATOR" enabling scaling up of Startups and existing businesses in Industrial IoT space. Mentoring and Guidance includes - Refining concepts and aligning them with present and future Industry needs and facilitating industry & investment tie ups enabling business expansion

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. There are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: general economic business conditions, competitive and technological factors, markets, services, products and prices, availability and the cost of capital, success of growth initiatives, limited operating history and other factors discussed in our filings with the Securities and Exchange Commissions. Additionally, this release may not be considered as legal, accounting, or investment advice, and is not, and may not be considered, a solicitation for the purchase of any securities issued by Affluence Corporation.

For further information contact Affluence Corporation Investor Relations at 720-295-6409.

SOURCE: Affluence Corporation



View source version on accesswire.com:
https://www.accesswire.com/666812/Affluence-Corporation-Announces-Entry-into-76-Billion-Biomedical-Waste-Market-Through-Acquisition-of-Saamarthya

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.